LAPATINIB and DRUG INEFFECTIVE

Overview

DRUG INEFFECTIVE is the #11 most commonly reported adverse reaction for LAPATINIB, manufactured by Novartis Pharmaceuticals Corporation. There are 559 FDA adverse event reports linking LAPATINIB to DRUG INEFFECTIVE. This represents approximately 1.7% of all 32,865 adverse event reports for this drug.

Patients taking LAPATINIB who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DRUG INEFFECTIVE559 of 32,865 reports

DRUG INEFFECTIVE is a less commonly reported adverse event for LAPATINIB, but still significant enough to appear in the safety profile.

Other Side Effects of LAPATINIB

In addition to drug ineffective, the following adverse reactions have been reported for LAPATINIB:

DIARRHOEA — 4,171 reports
NAUSEA — 1,612 reports
DEATH — 1,453 reports
FATIGUE — 1,304 reports
VOMITING — 1,205 reports
RASH — 1,061 reports
DISEASE PROGRESSION — 997 reports
PALMAR PLANTAR ERYTHRODYSAESTHESIA SYNDROME — 919 reports
ASTHENIA — 603 reports
DYSPNOEA — 561 reports

Other Drugs Associated with DRUG INEFFECTIVE

The following drugs have also been linked to drug ineffective in FDA adverse event reports:

0XYGEN ABACAVIR SULFATE ABATACEPT ABEMACICLIB ABIRATERONE ACETATE ACETAMINOPHEN ACETAMINOPHEN 500 MG ACETAMINOPHEN 500MG ACETAMINOPHEN AND CODEINE ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE ACETAMINOPHEN AND IBUPROFEN ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, ASPIRIN, AND CAFFEINE ACETAMINOPHEN, ASPIRIN, CAFFEINE ACETAMINOPHEN, ASPIRIN (NSAID) AND CAFFEINE ACETAMINOPHEN, CAFFEINE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL ACETAMINOPHEN, DEXTROMETHORPHAN HBR ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE

Does LAPATINIB cause DRUG INEFFECTIVE?

DRUG INEFFECTIVE has been reported as an adverse event in 559 FDA reports for LAPATINIB. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DRUG INEFFECTIVE with LAPATINIB?

DRUG INEFFECTIVE accounts for approximately 1.7% of all adverse event reports for LAPATINIB, making it a notable side effect.

What should I do if I experience DRUG INEFFECTIVE while taking LAPATINIB?

If you experience drug ineffective while taking LAPATINIB, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.